Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $158,981 - $238,785
2,411 Added 392.67%
3,025 $206,000
Q1 2023

May 12, 2023

BUY
$47.19 - $70.77 $21,282 - $31,917
451 Added 276.69%
614 $41,000
Q4 2022

Feb 09, 2023

SELL
$30.35 - $53.15 $11,108 - $19,452
-366 Reduced 69.19%
163 $8,000
Q3 2022

Nov 10, 2022

SELL
$31.97 - $49.37 $3,932 - $6,072
-123 Reduced 18.87%
529 $17,000
Q2 2022

Aug 05, 2022

SELL
$35.61 - $76.23 $8,261 - $17,685
-232 Reduced 26.24%
652 $26,000
Q1 2022

May 12, 2022

BUY
$57.56 - $82.54 $50,883 - $72,965
884 New
884 $62,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Pine Bridge Investments, L.P. Portfolio

Follow Pine Bridge Investments, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Pine Bridge Investments, L.P. with notifications on news.